| Literature DB >> 31449780 |
Marcelo C Pasquini1, Alok Srivastava2, Syed Osman Ahmed3, Mahmoud Aljurf3, Yoshiko Atsuta4, Carol Doleysh5, Sebastian Galeano6, Eliane Gluckman7, Hildegard Greinix8, Gregory Hale9, Parameswaran Hari5, Shahrukh K Hashmi3, Naynesh Kamani10, Mary J Laughlin11, Dietger Niederwieser12, Adriana Seber13, Jeffrey Szer14, John A Snowden15, Koen Van Biesen16, Paula Watry5, Daniel J Weisdorf17, Jane Apperley18.
Abstract
Hematopoietic cell transplantation (HCT) is a highly complex procedure that requires a dedicated multidisciplinary team to optimize its safety. In addition, institutions may have different needs regarding indications based on regional disease prevalence or may have an interest in developing specialized services. Yet, structured recommendations are not commonly available. Here, the Transplant Center and Recipient Issues Standing Committee for the Worldwide Network for Blood and Marrow Transplantation (WBMT) organized a structured review of all pertinent elements to establish a transplant program. First, we solicited components from committee members and grouped them in domains (infrastructure, staff, cell processing laboratory, blood banking, laboratory, radiology, pharmacy, HLA testing, ancillary services and quality). Subsequently, reviewers scored all elements on a 7-point scale, from an absolute requirement (score of 1) to not required (score of 7). An independent group of five experienced transplant physicians reviewed the rankings. Minimum requirements to establish any HCT program were identified among elements with mean score of ≤2.0, and specific elements for allogeneic and autologous HCT were identified. Mean scores >2.0-4.0 were classified as preferred recommendation, and mean scores of >4.0 to ≤7.0 were considered ideal recommendations for advanced and complex types of transplantation. This structured set of recommendations guides the prioritization of minimum requirements to establish a transplant program and to set the path for expansion and further development.Entities:
Keywords: Autologous vs. allogeneic transplants; Transplant program requirements
Mesh:
Year: 2019 PMID: 31449780 PMCID: PMC7125509 DOI: 10.1016/j.hemonc.2019.08.001
Source DB: PubMed Journal: Hematol Oncol Stem Cell Ther